japanese encephalitis After recent press news about Japanese Encephalitis I was dissapointed to note that Panbio did not have a test for it. Then came todays ann!
Bioshares staff finally sold their holding of pbo & put a sell recommendation on it. That's not always a bad thing. They seem to have a history of miss-calling.
Not too bad a company developing here. They make a small loss, but that could soon be turned into a profit following developments like todays. A good new technology soon to come out & a major one being developed, that might appear at the end of next year.
Lots of upside & little risk. Worth keeping an eye on, imho.
PBO
panbio limited
